Novel Antibody Prevents Infection By Hepatitis C Virus, Massachusetts Biologic Laboratories Study
5/5/2009 11:56:39 AM
EurekAlert! -- Boston, Mass. — Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV). The new antibody effectively neutralized the virus in culture, and then prevented infection by the virus in a pre-clinical animal model of the disease.